ScholarIQanswers from OpenAlex
Clinical Trial Investigators
InstitutionResearch output, impact & collaborations
Clinical Trial Investigators is a institution indexed in ScholarIQ from OpenAlex.
What is known about Clinical Trial Investigators?
ScholarIQrecord summary
Clinical Trial Investigators is a research organisation in Tustin, US. OpenAlex records 149 works and 326,665 citations for it. 2,691 researchers list it as their most recent affiliation.
How many works does Clinical Trial Investigators have?
ScholarIQindexed works
Clinical Trial Investigators has 149 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Clinical Trial Investigators have?
ScholarIQcitation count
Clinical Trial Investigators has 326,665 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Clinical Trial Investigators?
ScholarIQresearcher count
Clinical Trial Investigators has 2,691 researchers in the ScholarIQ index.
What is the average h-index at Clinical Trial Investigators?
ScholarIQavg h-index
Clinical Trial Investigators has an average h-index of 57.8 in OpenAlex.
What is the ROR of Clinical Trial Investigators?
ScholarIQror
The ROR for Clinical Trial Investigators is on the source record.
What is the OpenAlex record for Clinical Trial Investigators?
ScholarIQopenalex
The OpenAlex for Clinical Trial Investigators is on the source record.
Who are the most-cited researchers behind Clinical Trial Investigators?
ScholarIQtop researchers by citations
What are the most-cited papers on Clinical Trial Investigators?
ScholarIQmost cited works
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
John J. Nolan, Bernhard Ludvik, P. Beerdsen, M. Joyce, Jerrold M. Olefsky
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)
Judy Savige, David Gillis, Elizabeth M. Benson, D.J.G. Davies, Vincent Esnault, Ronald J. Falk, E. Chris Hagen, David Jayne, J. Charles Jennette, Bill Paspaliaris, Wendy Pollock, Charles D. Pusey, Caroline O. S. Savage, Roger Silvestrini, Fokko van der Woude, Jörgen Wieslander, Allan Wiik
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux, Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortíz, John P H Wilding, Trine Vang Skjøth, Linda Shapiro Manning, Xavier Pi-Sunyer, A. Hamann, Alain Barakat, Matthias Blüher, Thomas Linn, Andrea Mölle, Alexander Segner, Petra Stübler, Regina Tosch-Sisting, Furio Pacini, Ferruccio Santini, Giulio Marchesini, Carlo Maria Rotella, Cecilia Invitti, Roberto Vettor, Silvio Buscemi, Pedro Mezquita Raya, Felipe Casanueva Freijoo, Ramón Gomis de Barbará, Raffaele Carraro, Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Vernon Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudesh Kumar, Carel Wynard Le Roux, Carel Wynard Le Roux, Michael E.J. Lean, Barbara McGowan, Tariq Rehman, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, Ambika Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos
A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test
Andrea Mari, Giovanni Pacini, Elaine Murphy, Bernhard Ludvik, John J. Nolan
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Bernhard Ludvik, Francesco Giorgino, Esteban Jódar, Juan P. Frías, Laura Fernández Landó, Katelyn Brown, Ross Bray, Ángel Rodríguez
How much of the research on Clinical Trial Investigators is open access?
ScholarIQopen access share
42%OPEN ACCESS